1.1Electrodes integrated into pacing capsules
Each capsule contains a battery, a pulse circuit, a tip electrode, and a return electrode on its housing. Atrial and ventricular capsules exchange timing signals to coordinate their pacing pulses.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
Each capsule contains a battery, a pulse circuit, a tip electrode, and a return electrode on its housing. Atrial and ventricular capsules exchange timing signals to coordinate their pacing pulses.
Transvenous leads place electrodes against the right atrial and right ventricular endocardium, and a transseptal lead places an electrode against the left ventricular endocardium. Separate output channels set the timing and pulse amplitude for each chamber.
An insulated conductor connects the distal electrode to the pulse generator, and the exposed titanium housing completes the circuit through body tissue. The generator senses ventricular depolarization and delivers a pacing pulse when the programmed escape interval expires.
Separate bipolar electrode pairs contact the right atrial and right ventricular surfaces. An atrial sensed event or pacing pulse starts an atrioventricular delay, and the device paces the right ventricle if it senses no ventricular event before the delay expires.
Temporary wires attached to the heart surface exit through the skin and plug into the external generator. The generator senses cardiac activity through the wires and sends timed pulses through selected electrode pairs.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
An implantable pulse generator connects to three bipolar electrode pairs in a veterinary cardiac physiology study. The leads attach to the outer surfaces of the right atrium, right ventricle, and left ventricle of a large mammal, with one pair at each chamber. A research workstation sends timing settings over a telemetry link and records pulse markers alongside surface electrocardiogram and arterial pressure signals.
A flexible polyimide circuit replaces round-wire leads with individually routed copper traces and platinum-iridium electrode pads. Three flexible branches carry paired pads to the outer surfaces of the right atrium, right ventricle, and left ventricle. A silicone overmold covers the traces and leaves the tissue-facing pad surfaces exposed. The implantable pulse generator connects to the traces through a sealed feedthrough and drives each pair as a bipolar pacing output.
Twelve contacts form three groups of four on flexible carriers placed against the outer surfaces of the right atrium, right ventricle, and left ventricle. Each group arranges its contacts in a two-by-two grid with 5 mm center-to-center spacing along each axis. A switch matrix connects two contacts to the implantable pulse generator for each chamber and supports six distinct contact pairings per group. During setup, the generator records the capture threshold for each pairing and stores one pairing per chamber for pacing.
An implantable pulse generator drives bipolar electrode pairs on the outer surfaces of the right atrium, right ventricle, and left ventricle. A catheter-tip pressure sensor connects to an external hemodynamic recorder during pacing setup. A telemetry receiver converts chamber-specific pulse markers into digital inputs for the recorder, which samples the markers and the pressure waveform on the same time base. The recorded traces show the interval from each pacing pulse to the onset of the ventricular pressure rise.
An implantable pulse generator connects to a bipolar pacing pair and a separate sensing pair at each of three extracardiac sites adjacent to the right atrium, right ventricle, and left ventricle. After each test pulse, the sensing amplifier waits through a programmable blanking interval and samples the local evoked response within a chamber-specific time window. The controller tests one chamber at a time, steps pulse amplitude down at a fixed pulse width, and stores the lowest setting that repeatedly produces a response. If a test pulse fails to produce a response, the generator delivers a backup pulse and sets the pacing amplitude above the last confirmed threshold by a programmed margin.
A three-axis accelerometer inside the implantable pulse generator measures body motion while three extracardiac bipolar electrode pairs deliver pacing to the right atrium, right ventricle, and left ventricle. The controller filters the acceleration samples, computes a rolling activity level, and maps that level to a target rate between programmed lower and upper limits. A rate limiter smooths changes in the target rate, and the pacing scheduler uses the resulting interval while applying programmed delays between chamber outputs.
Three flexible silicone pads each carry a pair of platinum-iridium contacts. Suture tabs hold the pads against the right atrial, right ventricular, and left ventricular surfaces, and insulated conductors connect the contact pairs to the pulse generator.
A flexible lead places four ring electrodes at intervals along a coronary vein over the left ventricle. The pulse generator selects two rings for left ventricular pacing, and separate epicardial leads provide right atrial and right ventricular pacing.
A hermetic titanium enclosure contains a lithium cell, timing logic, and three separately programmable output circuits. Ceramic feedthroughs connect the circuits to lead terminals, and each channel stores its own pulse amplitude and duration.
An atrial sensing amplifier detects a right atrial depolarization or records the timing of an atrial pacing pulse. The controller starts an atrioventricular delay from that event and uses a programmable offset between the right and left ventricular pulses when both outputs are scheduled.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
Depending on the patient's need and the type of the pacing therapy to be delivered, the pacing lead implantation includes placement of one or more intracardiac leads each having one or more electrodes disposed within the heart, and/or one or more epicardial leads having one or more electrodes disposed on the heart.A · US 8,761,878 B2 · ¶ 68
Lead system 150 provides electrical connections between implantable pacemaker 110B and heart 105. It includes one or more pacing leads each having one or more electrodes for sensing intracardiac electrogram and delivering pacing pulses.A · US 8,761,878 B2 · ¶ 38
Multi-chamber pacemakers are also available that may be coupled to three leads for positioning electrodes for pacing and sensing in one atrial chamber and both the right and left ventricles.B · US 2020/0038664 A1 · ¶ 3
An empty cell means only that no passage was reproduced there.
The evaluation becomes difficult when the patient's abnormal conditions, or symptoms, occur occasionally or intermittently.A · US 8,761,878 B2 · ¶ 5
That is, two separate implantable medical devices are needed, imposing a high cost upon the patient or another responsible party, such as an insurer or a hospital.A · US 8,761,878 B2 · ¶ 6
The disclosure relates to an implantable medical device system and associated method for controlling the monitoring and therapy delivery functions of an intracardiac pacing device.B · US 2020/0038664 A1 · ¶ 2
patent.fyi, US 2026/0355523 A1, claim 1, first published 2026-11-19T12:45:34-05:00, https://patent.fyi/US20260355523/, SHA-256 488ddd4da62f2c8755425de6d98a35279d59cad7e6ed6585ee2fcd2384668ca4